Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
- 1 June 1993
- journal article
- Published by Springer Nature in Nature
- Vol. 363 (6428) , 458-460
- https://doi.org/10.1038/363458a0
Abstract
Multiple endocrine neoplasia type 2A (MEN 2A) is a dominantly inherited cancer syndrome that affects tissues derived from neural ectoderm. It is characterized by medullary thyroid carcinoma (MTC) and phaeochromocytoma. The MEN2A gene has recently been localized by a combination of genetic and physical mapping techniques to a 480-kilobase region in chromosome 10q11.2 (refs 2,3). The DNA segment encompasses the RET proto-oncogene, a receptor tyrosine kinase gene expressed in MTC and phaeochromocytoma and at lower levels in normal human thyroid. This suggested RET as a candidate for the MEN2A gene. We have identified missense mutations of the RET proto-oncogene in 20 of 23 apparently distinct MEN 2A families, but not in 23 normal controls. Further, 19 of these 20 mutations affect the same conserved cysteine residue at the boundary of the RET extracellular and transmembrane domains.Keywords
This publication has 13 references indexed in Scilit:
- Genetic events in tumour initiation and progression in multiple endocrine neoplasia type 2Genes, Chromosomes and Cancer, 1993
- Genetic linkage studies map the multiple endocrine neoplasia type 2 loci to a small interval on chromosome 10q11.2Human Molecular Genetics, 1993
- Localisation of the gene for multiple endocrine neoplasia type 2A to a 480 kb region in chromosome band 10q11.2Human Molecular Genetics, 1993
- A Taql RFLP in the humanretproto-oncogeneNucleic Acids Research, 1990
- Development of multiple endocrine neoplasia type 2A does not involve substantial deletions of chromosome 10Genomics, 1989
- A point mutation in the extracellular domain of the human CSF-1 receptor (c-fms proto-oncogene product) activates its transforming potentialCell, 1988
- Reactivity of cytosine and thymine in single-base-pair mismatches with hydroxylamine and osmium tetroxide and its application to the study of mutations.Proceedings of the National Academy of Sciences, 1988
- A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastasesNature, 1987
- Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185Cell, 1986
- Genetic Aspects of Multiple Endocrine NeoplasiaAnnual Review of Medicine, 1984